Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 13 results.
User Information
Export Records
  1. 1.   MoMo30 Binds to SARS-CoV-2 Spike Variants and Blocks Infection by SARS-CoV-2 Pseudovirus
  2. DeBarros, Kenya; Khan, Mahfuz; Coleman, Morgan; Bond, Vincent C; Floyd, Virginia; Gbodossou, Erick; Diop, Amad; Krumpe,Lauren; O'Keefe,Barry; Powell, Michael D
  3. Viruses. 2024, Sep 07; 16(9):
  1. 2.   Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge
  2. Felber,Barbara; Lu, Zhongyan; Hu, Xintao; Valentin,Antonio; Rosati,Margherita; Remmel, Christopher A L; Weiner, Joshua A; Carpenter, Margaret C; Faircloth, Katelyn; Stanfield-Oakley, Sherry; Williams, Wilton B; Shen, Xiaoying; Tomaras, Georgia D; LaBranche, Celia C; Montefiori, David; Trinh, Hung V; Rao, Mangala; Alam, Munir S; Vandergrift, Nathan A; Saunders, Kevin O; Wang, Yunfei; Rountree, Wes; Das, Jishnu; Alter, Galit; Reed, Steven G; Aye, Pyone P; Schiro, Faith; Pahar, Bapi; Dufour, Jason P; Veazey, Ronald S; Marx, Preston A; Venzon, David J; Shaw, George M; Ferrari, Guido; Ackerman, Margaret E; Haynes, Barton F; Pavlakis,George
  3. Cell reports. 2020, May 12; 31(6): 107624.
  1. 3.   Loss of tetherin antagonism by Nef impairs SIV replication during acute infection of rhesus macaques
  2. Tavakoli-Tameh, Aidin; Janaka, Sanath Kumar; Zarbock, Katie; O'Connor, Shelby; Crosno, Kristin; Capuano, Saverio; Uno, Hajime; Lifson,Jeffrey; Evans, David T
  3. PLoS pathogens. 2020, Apr 17; 16(4): e1008487.
  1. 4.   AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challenges
  2. Gardner, Matthew R; Fellinger, Christoph H; Kattenhorn, Lisa M; Davis-Gardner, Meredith E; Weber, Jesse A; Alfant, Barnett; Zhou, Amber S; Prasad, Neha R; Kondur, Hema R; Newton, Wendy A; Weisgrau, Kimberly L; Rakasz, Eva G; Lifson,Jeffrey; Gao, Guangping; Schultz-Darken, Nancy; Farzan, Michael
  3. Science translational medicine. 2019, Jul 24; 11(502): pii: eaau5409.
  1. 5.   Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies
  2. Gardner, Matthew R.; Fetzer, Ina; Kattenhorn, Lisa M.; Davis-Gardner, Meredith E.; Zhou, Amber S.; Alfant, Barnett; Weber, Jesse A.; Kondur, Hema R.; Martinez-Navio, Jose M.; Fuchs, Sebastian P.; Desrosiers, Ronald C.; Gao, Guangping; Lifson,Jeffrey; Farzan, Michael
  3. Molecular therapy : the journal of the American Society of Gene Therapy. 2019, Mar 6; 27(3): 650-660.
  1. 6.   The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability
  2. Jiang, J. Y.; Ablan, S. D.; Derebail, S.; Hercik, K.; Soheilian, F.; Thomas, J. A.; Tang, S. X.; Hewlett, I.; Nagashima, K.; Gorelick, R. J.; Freed, E. O.; Levin, J. G.
  3. Virology. 2011, Dec; 421(2): 253-265.
  1. 7.   Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41
  2. Ashkenazi, A.; Viard, M.; Wexler-Cohen, Y.; Blumenthal, R.; Shai, Y.
  3. Faseb Journal. 2011, Jul; 25(7): 2156-2166.
  1. 8.   Antiviral activity of alpha-helical stapled peptides designed from the HIV-1 capsid dimerization domain
  2. Zhang, H. T.; Curreli, F.; Zhang, X. H.; Bhattacharya, S.; Waheed, A. A.; Cooper, A.; Cowburn, D.; Freed, E. O.; Debnath, A. K.
  3. Retrovirology. 2011, May; 8: 18.
  1. 9.   Identification of Specific Determinants of Human APOBEC3F, APOBEC3C, and APOBEC3DE and African Green Monkey APOBEC3F That Interact with HIV-1 Vif
  2. Smith, J. L.; Pathak, V. K.
  3. Journal of Virology. 2010, Dec; 84(24): 12599-12608.
  1. 10.   APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA
  2. Russell, R. A.; Moore, M. D.; Hu, W. S.; Pathak, V. K.
  3. Retrovirology. 2009 6: 16.
  1. 11.   Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 Vif
  2. Russell, R. A.; Smith, J.; Barr, R.; Bhattacharyya, D.; Pathak, V. K.
  3. Journal of Virology. 2009 83(4): 1992-2003.
  1. 12.   Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F
  2. Russell, R. A.; Pathak, V. K.
  3. Journal of Virology. 2007, Aug; 81(15): 8201-8210.
  1. 13.   A second-site suppressor significantly improves the defective phenotype impolsed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein
  2. Tang, S. X.; Ablan, S.; Dueck, M.; Ayala-Lopez, W.; Soto, B.; Caplan, M.; Nagashima, K.; Hewlett, I. K.; Freed, E. O.; Levin, J. G.
  3. Virology. 2007, Mar; 359(1): 105-115.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel